A5067183118- interferon and immune responses
- Platelet Disorders and Treatments
- Hematological disorders and diagnostics
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Genomic variations and chromosomal abnormalities
- Lung Cancer Treatments and Mutations
- NF-κB Signaling Pathways
- Acute Myeloid Leukemia Research
- RNA modifications and cancer
- Cardiac Arrhythmias and Treatments
- Prenatal Screening and Diagnostics
- Thyroid Disorders and Treatments
- Blood disorders and treatments
- Shoulder Injury and Treatment
- Chromatin Remodeling and Cancer
- RNA regulation and disease
- Ferroptosis and cancer prognosis
- Genetics and Neurodevelopmental Disorders
- Ocular Oncology and Treatments
Hospital Universitario 12 De Octubre
2018-2024
Instituto de Investigación Biomédica de Salamanca
2012
Lung cancer is one of the most commonly diagnosed cancers worldwide. It leading cause cancer-related deaths in both men and women. In 2020, there were an estimated 2.2 million new cases lung 1.8 due to disease. Historically, has been more common men, but gap closing. Smoking tobacco cancer. Survival rates for vary greatly depending on stage at diagnosis other factors. Overall, prognosis often poor, with a relatively low five-year survival rate compared some cancers. this work we aim show...
ABSTRACT TRAF7 syndrome, a multisystemic neurodevelopmental disorder caused by germline missense variants in the gene, exhibits heterogeneous clinical presentations. We present detailed description of eleven new syndrome cases, featuring eight distinct variants, including novel one. Phenotypic analysis and comprehensive review 58 previously reported cases outline consistent presentations, emphasizing dysmorphic features, developmental delay, endocrine manifestations, cardiac defects. In this...